The aesthetic injectable market in Thailand is expected to reach a projected revenue of US$ 323.2 million by 2033. A compound annual growth rate of 12.2% is expected of Thailand aesthetic injectable market from 2026 to 2033.
Ipsen SA, AbbVie Inc, Merz Pharma, Galderma Group AG Registered Shares, Prollenium Medical Technologies, Suneva Medical, Sinclair Pharma plc, Medytox, Revance Therapeutics Inc
Other key industry trends
In terms of revenue, Thailand accounted for 1.2% of the global aesthetic injectable market in 2025.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
In Asia Pacific, China aesthetic injectable market is projected to lead the regional market in terms of revenue in 2033.
Vietnam is the fastest growing regional market in Asia Pacific and is projected to reach USD 72.1 million by 2033.
The availability of advanced & noninvasive cosmetic solutions and the rising number of cosmetic surgeries are boosting the market demand in Thailand. According to the ISAPS report 2022, the Thailand aesthetic injectable market witnessed a significant surge, with 7,233 procedures conducted, constituting 16.7% of the 43,429 total nonsurgical procedures.
This robust demand positions HA treatments as the country’s second most common nonsurgical procedure. The availability of 475 surgeons further enhances the accessibility of these treatments, showcasing a thriving landscape for aesthetic interventions in Thailand.
The increasing hospital infrastructure indicates a favorable environment for cosmetic procedures, while the extensive international patient percentage highlights the country’s attractiveness as a medical tourism destination.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Aesthetic Injectable Market will help companies and investors design strategic landscapes.
Hyaluronic Acid was the largest segment with a revenue share of 62.01% in 2025.
Horizon Databook has segmented the Thailand aesthetic injectable market based on collagen and pmma microspheres, hyaluronic acid, calcium hydroxylapatite (caha), plla, pcl, pn/pdrn, botulinum toxin (botox) covering the revenue growth of each sub-segment from 2021 to 2033.
The availability of advanced & noninvasive cosmetic solutions and the rising number of cosmetic surgeries are boosting the market demand in Thailand. According to the ISAPS report 2022, the Thailand aesthetic injectable market witnessed a significant surge, with 7,233 procedures conducted, constituting 16.7% of the 43,429 total nonsurgical procedures.
This robust demand positions HA treatments as the country’s second most common nonsurgical procedure. The availability of 475 surgeons further enhances the accessibility of these treatments, showcasing a thriving landscape for aesthetic interventions in Thailand.
The increasing hospital infrastructure indicates a favorable environment for cosmetic procedures, while the extensive international patient percentage highlights the country’s attractiveness as a medical tourism destination.
Thailand Aesthetic Injectable Market Product Outlook (Revenue, USD Million , 2021-2033)
Collagen and PMMA Microspheres
Hyaluronic Acid
Calcium Hydroxylapatite (CaHA)
PLLA
PCL
PN/PDRN
Botulinum Toxin (Botox)
Thailand Aesthetic Injectable Market Application Outlook (Revenue, USD Million , 2021-2033)
Wrinkle Correction
Lip Augmentation
Facial Contouring
Scar Treatment
Volume Loss Restoration
Others
Thailand Aesthetic Injectable Market End Use Outlook (Revenue, USD Million , 2021-2033)
MedSpas
Aesthetic Surgery Centers
Hospitals
Others
Reasons to subscribe to Aesthetic Injectable Market databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Aesthetic Injectable Market databook
Our clientele includes a mix of Aesthetic Injectable Market companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Thailand Aesthetic Injectable Market, including forecasts for subscribers. This country databook contains high-level insights into Thailand Aesthetic Injectable Market from 2021 to 2033, including revenue numbers, major trends, and company profiles.